Share Price and Basic Stock Data
Last Updated: November 3, 2025, 8:18 pm
| PEG Ratio | -6.24 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Bharat Rasayan Ltd operates in the agrochemicals and pesticides sector, demonstrating a robust market presence with a current market capitalization of ₹4,599 Cr. The company’s stock price stood at ₹11,068. Over the years, Bharat Rasayan has shown fluctuating revenue patterns, with sales reported at ₹1,301 Cr in FY 2022 and a subsequent decline to ₹1,234 Cr in FY 2023. The latest financial year, FY 2025, recorded sales of ₹1,171 Cr. Despite this dip, the trailing twelve months (TTM) sales rose to ₹1,268 Cr, indicating some recovery. Quarterly sales also reflected variability, with the most recent quarter (Jun 2025) reporting ₹377 Cr, suggesting a return to growth following a low of ₹239 Cr in Jun 2023. Seasonal demand fluctuations and competitive pressures may contribute to these revenue trends, which are critical for understanding the company’s market positioning.
Profitability and Efficiency Metrics
Bharat Rasayan’s profitability metrics reveal a mixed performance. The operating profit margin (OPM) stood at 18% as of the latest report, slightly below the sector average. The company’s net profit for FY 2025 was ₹141 Cr, translating to a net profit margin of 10.66%, which is lower than the industry’s typical margins. The interest coverage ratio (ICR) was an impressive 42.56x, indicating strong ability to meet interest obligations, a critical factor for investor confidence. However, the return on equity (ROE) at 12.47% and return on capital employed (ROCE) at 15.15% suggest a need for improvement when compared to sector benchmarks, which typically exceed 15% for leading firms. The cash conversion cycle (CCC) stood at 200 days, reflecting inefficiencies in managing inventory and receivables, which could impact liquidity if not addressed.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bharat Rasayan demonstrates solid financial health with total reserves increasing to ₹1,126 Cr and borrowings limited to ₹85 Cr, resulting in a low debt-to-equity ratio of 0.07. This conservative leverage indicates a strong reliance on internal financing for growth, reducing financial risk. The company’s current ratio of 4.19x and quick ratio of 3.08x significantly exceed the industry norms, showcasing robust liquidity and the ability to meet short-term obligations. However, the company’s price-to-book value (P/BV) ratio stood at 3.87x, suggesting that the stock may be trading at a premium compared to its book value, which could deter value-focused investors. Additionally, the enterprise value to EBITDA ratio of 21.94x points towards potentially high valuation, necessitating careful scrutiny from investors.
Shareholding Pattern and Investor Confidence
Bharat Rasayan’s shareholding structure reveals a strong promoter holding of 74.99%, indicating significant insider confidence in the business model. Foreign institutional investors (FIIs) have gradually increased their stake to 0.56%, while domestic institutional investors (DIIs) hold 2.74%. This distribution signals a cautious yet positive sentiment among institutional investors, reflecting a stable governance structure. The number of shareholders has fluctuated, standing at 15,668, which may indicate changing retail investor interest. The low public holding of 21.71% suggests potential for future capital raising if needed. The company’s effective management of shareholder interests, coupled with consistent performance metrics, can bolster investor confidence moving forward.
Outlook, Risks, and Final Insight
The outlook for Bharat Rasayan Ltd hinges on its ability to navigate industry challenges while capitalizing on growth opportunities. Strengths include its strong balance sheet, low debt levels, and high interest coverage ratio, which provide a cushion against economic downturns. However, risks such as fluctuating sales trends, lower profitability margins, and inefficiencies in working capital management could pose challenges. The company’s dependence on seasonal agricultural demand and potential increases in raw material costs may also impact future performance. For investors, a focus on operational efficiency and market adaptability will be crucial for sustained growth. Should the company enhance its profitability and manage its inventory more effectively, it could unlock significant shareholder value in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bharat Rasayan Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 7,315 Cr. | 1,698 | 2,243/1,502 | 17.0 | 441 | 0.35 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 893 Cr. | 265 | 391/165 | 17.1 | 117 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 55.8 Cr. | 107 | 148/55.2 | 10.2 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,222 Cr. | 248 | 392/228 | 113 | 53.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 775 Cr. | 327 | 670/244 | 11.3 | 320 | 0.92 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,553.15 Cr | 1,544.66 | 34.13 | 441.55 | 0.42% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 327 | 292 | 309 | 306 | 239 | 263 | 233 | 310 | 282 | 328 | 256 | 307 | 377 |
| Expenses | 276 | 256 | 260 | 249 | 234 | 250 | 207 | 240 | 244 | 281 | 215 | 270 | 308 |
| Operating Profit | 51 | 36 | 49 | 56 | 6 | 13 | 26 | 69 | 38 | 47 | 42 | 37 | 69 |
| OPM % | 16% | 12% | 16% | 18% | 2% | 5% | 11% | 22% | 14% | 14% | 16% | 12% | 18% |
| Other Income | 8 | 3 | 6 | -3 | 9 | 4 | 4 | 22 | 22 | 7 | 18 | 6 | -8 |
| Interest | 2 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 6 | 7 | 7 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 7 | 7 | 6 |
| Profit before tax | 51 | 31 | 46 | 46 | 8 | 10 | 22 | 84 | 53 | 46 | 52 | 35 | 54 |
| Tax % | 26% | 26% | 27% | 34% | 8% | 39% | 29% | 20% | 19% | 30% | 21% | 27% | 26% |
| Net Profit | 38 | 23 | 34 | 30 | 7 | 6 | 15 | 67 | 43 | 32 | 41 | 25 | 40 |
| EPS in Rs | 90.63 | 55.18 | 81.27 | 72.80 | 17.06 | 14.44 | 36.84 | 161.50 | 103.77 | 77.35 | 97.54 | 60.48 | 95.44 |
Last Updated: August 20, 2025, 12:50 pm
Below is a detailed analysis of the quarterly data for Bharat Rasayan Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 377.00 Cr.. The value appears strong and on an upward trend. It has increased from 307.00 Cr. (Mar 2025) to 377.00 Cr., marking an increase of 70.00 Cr..
- For Expenses, as of Jun 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 270.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 38.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 69.00 Cr., marking an increase of 32.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 18.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is -8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to -8.00 Cr., marking a decrease of 14.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2025) to 54.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 15.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 95.44. The value appears strong and on an upward trend. It has increased from 60.48 (Mar 2025) to 95.44, marking an increase of 34.96.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:36 am
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 989 | 1,213 | 1,091 | 1,301 | 1,234 | 1,044 | 1,171 | 1,268 |
| Expenses | 802 | 983 | 852 | 1,050 | 1,043 | 926 | 996 | 1,074 |
| Operating Profit | 188 | 230 | 240 | 250 | 191 | 118 | 175 | 195 |
| OPM % | 19% | 19% | 22% | 19% | 15% | 11% | 15% | 15% |
| Other Income | 1 | 14 | 6 | 16 | 15 | 35 | 42 | 23 |
| Interest | 16 | 16 | 4 | 7 | 6 | 3 | 5 | 5 |
| Depreciation | 17 | 22 | 26 | 25 | 26 | 26 | 27 | 27 |
| Profit before tax | 155 | 205 | 215 | 234 | 174 | 123 | 185 | 186 |
| Tax % | 28% | 23% | 24% | 25% | 28% | 23% | 24% | |
| Net Profit | 112 | 158 | 164 | 176 | 125 | 96 | 141 | 137 |
| EPS in Rs | 262.48 | 371.03 | 385.69 | 423.51 | 299.88 | 229.85 | 339.13 | 330.81 |
| Dividend Payout % | 1% | 0% | 0% | 0% | 0% | 1% | 0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 41.07% | 3.80% | 7.32% | -28.98% | -23.20% | 46.88% |
| Change in YoY Net Profit Growth (%) | 0.00% | -37.27% | 3.52% | -36.29% | 5.78% | 70.08% |
Bharat Rasayan Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -1% |
| 3 Years: | -3% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -9% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 2% |
| 3 Years: | -7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 12% |
| Last Year: | 12% |
Last Updated: September 5, 2025, 12:55 am
Balance Sheet
Last Updated: June 16, 2025, 12:22 pm
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves | 405 | 560 | 723 | 766 | 889 | 984 | 1,126 |
| Borrowings | 247 | 94 | 58 | 174 | 28 | 80 | 85 |
| Other Liabilities | 100 | 94 | 122 | 142 | 152 | 129 | 193 |
| Total Liabilities | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 |
| Fixed Assets | 150 | 203 | 191 | 228 | 225 | 230 | 230 |
| CWIP | 35 | 18 | 18 | 11 | 11 | 6 | 15 |
| Investments | 0 | 9 | 150 | 43 | 67 | 143 | 298 |
| Other Assets | 570 | 522 | 549 | 803 | 771 | 818 | 865 |
| Total Assets | 756 | 752 | 908 | 1,086 | 1,074 | 1,197 | 1,408 |
Below is a detailed analysis of the balance sheet data for Bharat Rasayan Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,126.00 Cr.. The value appears strong and on an upward trend. It has increased from 984.00 Cr. (Mar 2024) to 1,126.00 Cr., marking an increase of 142.00 Cr..
- For Borrowings, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 80.00 Cr. (Mar 2024) to 85.00 Cr., marking an increase of 5.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 129.00 Cr. (Mar 2024) to 193.00 Cr., marking an increase of 64.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,408.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 230.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 230.00 Cr..
- For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Mar 2025, the value is 298.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 155.00 Cr..
- For Other Assets, as of Mar 2025, the value is 865.00 Cr.. The value appears strong and on an upward trend. It has increased from 818.00 Cr. (Mar 2024) to 865.00 Cr., marking an increase of 47.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,408.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,197.00 Cr. (Mar 2024) to 1,408.00 Cr., marking an increase of 211.00 Cr..
Notably, the Reserves (1,126.00 Cr.) exceed the Borrowings (85.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Free Cash Flow | -59.00 | 136.00 | 182.00 | 76.00 | 163.00 | 38.00 | 90.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 75 | 99 | 130 | 96 | 138 | 131 |
| Inventory Days | 112 | 70 | 90 | 120 | 141 | 135 | 136 |
| Days Payable | 24 | 17 | 33 | 30 | 33 | 37 | 67 |
| Cash Conversion Cycle | 191 | 128 | 156 | 221 | 204 | 236 | 200 |
| Working Capital Days | 96 | 94 | 114 | 136 | 165 | 199 | 170 |
| ROCE % | 34% | 31% | 28% | 20% | 12% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| PGIM India Midcap Opportunities Fund | 63,964 | 0.58 | 57.67 | 63,964 | 2025-04-22 17:25:40 | 0% |
| PGIM India Small Cap Fund | 26,931 | 1.66 | 24.28 | 26,931 | 2025-04-22 15:57:00 | 0% |
| Quant Small Cap Fund | 16,063 | 0.09 | 14.48 | 16,063 | 2025-04-22 17:25:40 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Diluted EPS (Rs.) | 339.14 | 229.86 | 299.89 | 423.52 | 385.70 |
| Cash EPS (Rs.) | 366.02 | 258.47 | 377.50 | 486.31 | 447.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2719.48 | 2377.47 | 2149.86 | 1853.14 | 1711.78 |
| Revenue From Operations / Share (Rs.) | 2822.97 | 2514.02 | 2970.60 | 3131.39 | 2570.20 |
| PBDIT / Share (Rs.) | 483.49 | 332.50 | 521.37 | 651.03 | 580.53 |
| PBIT / Share (Rs.) | 418.54 | 270.43 | 458.73 | 591.01 | 519.90 |
| PBT / Share (Rs.) | 407.18 | 263.32 | 433.75 | 565.14 | 508.26 |
| Net Profit / Share (Rs.) | 301.07 | 196.40 | 314.86 | 426.29 | 387.10 |
| NP After MI And SOA / Share (Rs.) | 339.14 | 229.86 | 299.89 | 423.53 | 385.70 |
| PBDIT Margin (%) | 17.12 | 13.22 | 17.55 | 20.79 | 22.58 |
| PBIT Margin (%) | 14.82 | 10.75 | 15.44 | 18.87 | 20.22 |
| PBT Margin (%) | 14.42 | 10.47 | 14.60 | 18.04 | 19.77 |
| Net Profit Margin (%) | 10.66 | 7.81 | 10.59 | 13.61 | 15.06 |
| NP After MI And SOA Margin (%) | 12.01 | 9.14 | 10.09 | 13.52 | 15.00 |
| Return on Networth / Equity (%) | 12.47 | 9.66 | 13.94 | 22.85 | 22.53 |
| Return on Capital Employeed (%) | 15.15 | 11.23 | 21.10 | 31.43 | 29.94 |
| Return On Assets (%) | 10.00 | 7.97 | 11.60 | 16.14 | 18.04 |
| Total Debt / Equity (X) | 0.07 | 0.08 | 0.03 | 0.22 | 0.08 |
| Asset Turnover Ratio (%) | 0.90 | 0.91 | 1.14 | 1.30 | 1.32 |
| Current Ratio (X) | 4.19 | 4.60 | 4.64 | 2.59 | 3.82 |
| Quick Ratio (X) | 3.08 | 3.25 | 2.74 | 1.70 | 2.83 |
| Inventory Turnover Ratio (X) | 2.96 | 2.30 | 2.85 | 4.16 | 4.04 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.65 | 0.50 | 0.00 | 0.38 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.51 | 0.41 | 0.00 | 0.33 |
| Earning Retention Ratio (%) | 0.00 | 99.35 | 99.50 | 0.00 | 99.62 |
| Cash Earning Retention Ratio (%) | 0.00 | 99.49 | 99.59 | 0.00 | 99.67 |
| Interest Coverage Ratio (X) | 42.56 | 46.73 | 37.31 | 39.68 | 67.02 |
| Interest Coverage Ratio (Post Tax) (X) | 27.50 | 28.60 | 24.32 | 27.56 | 46.03 |
| Enterprise Value (Cr.) | 4407.24 | 3562.69 | 3772.42 | 5228.04 | 4021.85 |
| EV / Net Operating Revenue (X) | 3.76 | 3.41 | 3.06 | 4.02 | 3.68 |
| EV / EBITDA (X) | 21.94 | 25.79 | 17.41 | 19.33 | 16.31 |
| MarketCap / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| Retention Ratios (%) | 0.00 | 99.34 | 99.49 | 0.00 | 99.61 |
| Price / BV (X) | 3.87 | 3.57 | 4.23 | 6.57 | 5.49 |
| Price / Net Operating Revenue (X) | 3.73 | 3.38 | 3.06 | 3.89 | 3.66 |
| EarningsYield | 0.03 | 0.02 | 0.03 | 0.03 | 0.04 |
After reviewing the key financial ratios for Bharat Rasayan Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 366.02. This value is within the healthy range. It has increased from 258.47 (Mar 24) to 366.02, marking an increase of 107.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,719.48. It has increased from 2,377.47 (Mar 24) to 2,719.48, marking an increase of 342.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,822.97. It has increased from 2,514.02 (Mar 24) to 2,822.97, marking an increase of 308.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 483.49. This value is within the healthy range. It has increased from 332.50 (Mar 24) to 483.49, marking an increase of 150.99.
- For PBIT / Share (Rs.), as of Mar 25, the value is 418.54. This value is within the healthy range. It has increased from 270.43 (Mar 24) to 418.54, marking an increase of 148.11.
- For PBT / Share (Rs.), as of Mar 25, the value is 407.18. This value is within the healthy range. It has increased from 263.32 (Mar 24) to 407.18, marking an increase of 143.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 301.07. This value is within the healthy range. It has increased from 196.40 (Mar 24) to 301.07, marking an increase of 104.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 339.14. This value is within the healthy range. It has increased from 229.86 (Mar 24) to 339.14, marking an increase of 109.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.12. This value is within the healthy range. It has increased from 13.22 (Mar 24) to 17.12, marking an increase of 3.90.
- For PBIT Margin (%), as of Mar 25, the value is 14.82. This value is within the healthy range. It has increased from 10.75 (Mar 24) to 14.82, marking an increase of 4.07.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 10.47 (Mar 24) to 14.42, marking an increase of 3.95.
- For Net Profit Margin (%), as of Mar 25, the value is 10.66. This value exceeds the healthy maximum of 10. It has increased from 7.81 (Mar 24) to 10.66, marking an increase of 2.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 9.14 (Mar 24) to 12.01, marking an increase of 2.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has increased from 9.66 (Mar 24) to 12.47, marking an increase of 2.81.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.15. This value is within the healthy range. It has increased from 11.23 (Mar 24) to 15.15, marking an increase of 3.92.
- For Return On Assets (%), as of Mar 25, the value is 10.00. This value is within the healthy range. It has increased from 7.97 (Mar 24) to 10.00, marking an increase of 2.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.90. It has decreased from 0.91 (Mar 24) to 0.90, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.19. This value exceeds the healthy maximum of 3. It has decreased from 4.60 (Mar 24) to 4.19, marking a decrease of 0.41.
- For Quick Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 2. It has decreased from 3.25 (Mar 24) to 3.08, marking a decrease of 0.17.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.96. This value is below the healthy minimum of 4. It has increased from 2.30 (Mar 24) to 2.96, marking an increase of 0.66.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.65 (Mar 24) to 0.00, marking a decrease of 0.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.51 (Mar 24) to 0.00, marking a decrease of 0.51.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.35 (Mar 24) to 0.00, marking a decrease of 99.35.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.49 (Mar 24) to 0.00, marking a decrease of 99.49.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 42.56. This value is within the healthy range. It has decreased from 46.73 (Mar 24) to 42.56, marking a decrease of 4.17.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.50. This value is within the healthy range. It has decreased from 28.60 (Mar 24) to 27.50, marking a decrease of 1.10.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,407.24. It has increased from 3,562.69 (Mar 24) to 4,407.24, marking an increase of 844.55.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.76. This value exceeds the healthy maximum of 3. It has increased from 3.41 (Mar 24) to 3.76, marking an increase of 0.35.
- For EV / EBITDA (X), as of Mar 25, the value is 21.94. This value exceeds the healthy maximum of 15. It has decreased from 25.79 (Mar 24) to 21.94, marking a decrease of 3.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.34 (Mar 24) to 0.00, marking a decrease of 99.34.
- For Price / BV (X), as of Mar 25, the value is 3.87. This value exceeds the healthy maximum of 3. It has increased from 3.57 (Mar 24) to 3.87, marking an increase of 0.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 3. It has increased from 3.38 (Mar 24) to 3.73, marking an increase of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Rasayan Ltd:
- Net Profit Margin: 10.66%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.15% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 27.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.1 (Industry average Stock P/E: 34.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.66%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 1501, Vikram Tower, Rajendra Place, New Delhi Delhi 110008 | investors.brl@bharatgroup.co.in http://www.bharatgroup.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sat Narain Gupta | Chairman & Managing Director |
| Mr. Mahabir Prasad Gupta | Whole Time Director |
| Mr. Rajender Prasad Gupta | WholeTime Director & CEO |
| Mr. Ajay Gupta | Executive Director |
| Mr. Kamleshwar Prasad Uniyal | Executive Director |
| Mrs. Sujata Agarwal | Ind. Non-Executive Director |
| Mr. Suresh Kumar Garg | Ind. Non-Executive Director |
| Mr. Ankit Aggarwal | Ind. Non-Executive Director |
| Ms. Mukta Gupta | Ind. Non-Executive Director |
| Mr. Rajesh Gupta | Ind. Non-Executive Director |
| Mr. Naman Jain | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Bharat Rasayan Ltd?
Bharat Rasayan Ltd's intrinsic value (as of 03 November 2025) is 8119.53 which is 24.27% lower the current market price of 10,721.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,452 Cr. market cap, FY2025-2026 high/low of 12,550/8,798, reserves of ₹1,126 Cr, and liabilities of 1,408 Cr.
What is the Market Cap of Bharat Rasayan Ltd?
The Market Cap of Bharat Rasayan Ltd is 4,452 Cr..
What is the current Stock Price of Bharat Rasayan Ltd as on 03 November 2025?
The current stock price of Bharat Rasayan Ltd as on 03 November 2025 is 10,721.
What is the High / Low of Bharat Rasayan Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Rasayan Ltd stocks is 12,550/8,798.
What is the Stock P/E of Bharat Rasayan Ltd?
The Stock P/E of Bharat Rasayan Ltd is 30.1.
What is the Book Value of Bharat Rasayan Ltd?
The Book Value of Bharat Rasayan Ltd is 2,719.
What is the Dividend Yield of Bharat Rasayan Ltd?
The Dividend Yield of Bharat Rasayan Ltd is 0.01 %.
What is the ROCE of Bharat Rasayan Ltd?
The ROCE of Bharat Rasayan Ltd is 15.5 %.
What is the ROE of Bharat Rasayan Ltd?
The ROE of Bharat Rasayan Ltd is 12.4 %.
What is the Face Value of Bharat Rasayan Ltd?
The Face Value of Bharat Rasayan Ltd is 10.0.